Viking Global Investors LP Edwards Lifesciences Corp Transaction History

Viking Global Investors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $8.31 Million - $12.8 Million	-158,573 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$71.7 - $82.09 $3.27 Million - $3.74 Million	-45,575 Reduced 22.32%	158,573 $37 Million
Q3 2019 Nov 13, 2019	BUY	$61.55 - $75.43 $12.6 Million - $15.4 Million	204,148 New	204,148 $44.9 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

Stay updated on Viking Global Investors LP with notifications on news.